Sunday, February 5, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Outbreak News

NDAA Amendment Proposes Further Scale Up of PPE and Diagnostic Supplies

by Global Biodefense Staff
June 30, 2020
NDAA Amendment Proposes Further Scale Up of PPE and Diagnostic Supplies

Soldiers with the Delaware Army National Guard’s 262nd Component Repair Company, handle boxes of supplies at a coronavirus testing site on the grounds of the Sussex County VA Community-Based Outpatient Clinic in Georgetown, Delaware, May 6, 2020. Photo by Capt. Brendan Mackie

“We need more testing supplies, more testing, and more personal protective equipment for workers on the frontlines of this pandemic.”

U.S. Senator Tammy Baldwin (D-WI) has introduced an amendment to the National Defense Authorization Act of 2021 (NDAA) to scale up nation-wide production of the testing supplies, personal protective equipment, and medical equipment needed at the local level to address the ongoing COVID-19 pandemic.

Senator Baldwin’s amendment includes legislation she introduced in April with Senator Chris Murphy (D-CT). The Medical Supply Transparency and Delivery Act requires the president to utilize all available authorities under the Defense Production Act to mobilize a federal response to the pandemic through an equitable and transparent process. Key parts of Baldwin’s legislation are included in the House-passed HEROES Act, but the Republican majority in the Senate has not taken action on the legislation.

“New coronavirus cases are rising in states across the country, which means we need more testing supplies, more testing, and more personal protective equipment for workers on the frontlines of this pandemic,” said Senator Baldwin.

The NDAA is being considered on the Senate floor this week.

The full amendment is available here.

Tags: COVID-19Editor PickFrontline RespondersIndividual ProtectionLegislativePublic Health EmergencyRapid DiagnosticsSARS-CoV-2Supply Chain

Related Posts

Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
Officials Declare End to Ebola Outbreak in Uganda
Infectious Diseases

Officials Declare End to Ebola Outbreak in Uganda

January 11, 2023
A mother comforts her ill child and holds a hand to her forehead to test for temperature
Outbreak News

Strep A and Scarlet Fever: Signs and Symptoms

December 7, 2022
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC